Wiedbusch Elzbieta, Jason Leonard A
DePaul University, USA.
Arch Community Med. 2022;4(1):59-63. doi: 10.36959/547/653. Epub 2022 Apr 21.
A core criterion for Chronic Fatigue Syndrome (CFS) and Myalgic Encephalomyelitis (ME) is a substantial reduction in functioning from pre-illness levels. Despite its ubiquity in diagnostic criteria, there is considerable debate regarding how to measure this domain. The current study assesses five distinct methods for measuring substantial reductions. The analysis used an international, aggregated dataset of patients (N = 2,368) and controls (N=359) to compare the effectiveness of each method. Four methods involved sophisticated analytic approaches using the Medical Outcomes Survey Short Form-36; the fifth method included a single self-report item on the DePaul Symptom Questionnaire (DSQ). Our main finding was that all methods produced comparable results, though the DSQ item was the most valid in differentiating patients from controls. Having a simple, reliable method to capture a substantial reduction in functioning has considerable advantages for patients and health care workers.
慢性疲劳综合征(CFS)和肌痛性脑脊髓炎(ME)的一项核心标准是功能较患病前水平大幅下降。尽管这一标准在诊断标准中普遍存在,但对于如何衡量这一领域仍存在相当大的争议。本研究评估了五种测量大幅下降的不同方法。分析使用了一个国际综合数据集,其中包括患者(N = 2368)和对照组(N = 359),以比较每种方法的有效性。四种方法涉及使用医学结果调查简表36的复杂分析方法;第五种方法包括德保罗症状问卷(DSQ)上的一个单一自我报告项目。我们的主要发现是,所有方法都产生了可比的结果,尽管DSQ项目在区分患者和对照组方面最有效。拥有一种简单、可靠的方法来捕捉功能的大幅下降对患者和医护人员具有相当大的优势。